• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用舒必利试验对各种神经内分泌疾病中多巴胺能系统的研究]

[Study of the dopaminergic system in various neuroendocrine diseases using the sulpiride test].

作者信息

Marova E I, Avakian M R, Kirpatovskaia L E

出版信息

Probl Endokrinol (Mosk). 1991 Sep-Oct;37(5):10-3.

PMID:1780277
Abstract

Altogether 25 patients with acromegaly, 19 patients with prolactinomas, and 6 patients with nonfunctioning hypophyseal tumors (NHT) were investigated. Dopaminergic regulation of PRL, STH, TSH, LH and FSH was investigated with sulpiride (an antagonist of peripheral action) in all the patients. In acromegaly, irrespective of the presence of hyperprolactinemia, one can observe dysfunction of the central dopaminergic system (DAE) and DAE-regulation of adenohypophyseal hormones. Signs of disordered hormonal DAE-regulation are disorder of the normal ejection of PRL and pathological ejection of TSH in response to administration of DA antagonists. The results of investigations revealed both an enhanced tone of the DAE-system and insufficiency of DAE-control of hormonal secretion in patients with different hypophyseal tumors and other neuroendocrine diseases.

摘要

共对25例肢端肥大症患者、19例催乳素瘤患者和6例无功能垂体瘤(NHT)患者进行了研究。对所有患者使用舒必利(一种外周作用拮抗剂)研究了多巴胺能对催乳素(PRL)、生长激素(STH)、促甲状腺激素(TSH)、促黄体生成素(LH)和促卵泡生成素(FSH)的调节作用。在肢端肥大症中,无论是否存在高催乳素血症,均可观察到中枢多巴胺能系统(DAE)功能障碍以及腺垂体激素的DAE调节异常。激素DAE调节紊乱的迹象是,给予多巴胺拮抗剂后,PRL正常分泌紊乱以及TSH异常分泌。研究结果显示,不同垂体瘤患者和其他神经内分泌疾病患者中,DAE系统的张力增强,且DAE对激素分泌的控制不足。

相似文献

1
[Study of the dopaminergic system in various neuroendocrine diseases using the sulpiride test].[使用舒必利试验对各种神经内分泌疾病中多巴胺能系统的研究]
Probl Endokrinol (Mosk). 1991 Sep-Oct;37(5):10-3.
2
[Dopaminergic regulation of the hypothalamo-hypophyseal system in patients with hypophyseal adenomas].[垂体腺瘤患者下丘脑 - 垂体系统的多巴胺能调节]
Probl Endokrinol (Mosk). 1989 Sep-Oct;35(5):3-6.
3
Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.泌乳素分泌型垂体瘤患者中多巴胺能对泌乳素分泌的抑制作用的中枢神经系统成分缺失。
J Clin Invest. 1978 Apr;61(4):973-80. doi: 10.1172/JCI109022.
4
Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.白血病抑制因子调节催乳素瘤和催乳素细胞中催乳素的分泌。
J Clin Endocrinol Metab. 2003 Feb;88(2):858-63. doi: 10.1210/jc.2002-021281.
5
Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.垂体肿瘤分泌糖蛋白激素α亚基。
J Clin Endocrinol Metab. 1987 Jun;64(6):1187-93. doi: 10.1210/jcem-64-6-1187.
6
[Endocrinological evaluation of sellar and suprasellar tumor cases (the sixth report)-on pituitary hormone secretion of acromegalic patients before treatment (author's transl)].
No Shinkei Geka. 1976 May;4(5):465-70.
7
[The effect of luliberin and sulpiride on the secretion of gonadotropic hormones and prolactin in patients with obesity].[促性腺激素释放激素和舒必利对肥胖患者促性腺激素和催乳素分泌的影响]
Probl Endokrinol (Mosk). 1990 May-Jun;36(3):23-8.
8
[Mechanisms of disturbance of the secretion of prolactin in patients with acromegaly].[肢端肥大症患者催乳素分泌紊乱的机制]
Probl Endokrinol (Mosk). 1988 Sep-Oct;34(5):24-8.
9
Pituitary prolactin-secreting tumor formation: recent developments.垂体催乳素分泌瘤的形成:最新进展
Biol Signals Recept. 2000 Jan-Feb;9(1):1-20. doi: 10.1159/000014618.
10
Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide.泌乳素瘤患者多巴胺能张力的术后评估。II. 血浆促甲状腺激素对甲氧氯普胺的反应。
J Clin Endocrinol Metab. 1984 Mar;58(3):405-9. doi: 10.1210/jcem-58-3-405.